Barclays 29 (AJ19) News

Results must be a failure,

$TANH (@$.25) >>> Time to reload!? #Reversal #Overreaction

https://www.stockscores.com/chart.asp?TickerSymbol=tanh&TimeRange=60&Interval=60&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=830&ChartHeight=500&LogScale=None&Band=BB&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2

They already started trials
TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
April 15 2024 - 9:00AM


Share On Facebook

TransCode Therapeutics, Inc. (NASDAQ: RNA

Same. Might add here. Watching for the first hour probably.

Can we take a vote? How many here appreciate the thousands of hours of documentation and found it very useful over the years? Without that effort, I don't know where we would be today!

It smells worse than the Wuhan fish market here—trips soon, which should not be a surprise to anyone who actually did their due diligence.

Of course they are payed, 💯 %

What leaked?

There is no news. There is no update.

Why do you guys keep doing this?

No one on this forum has ever presented anything solid or verifiable. What I can’t figure out is why are Willy and TPP yanking our chain all the time? Why can’t you just let it go?

Newflow, thank you for sharing.

Oh boy

$NLST Interesting comments from Jason Sheasby in this interview regarding 417 in relation to the 912. PTAB is invalidating high value patents!

It’s all about personality
‘It’s all about personality’: Co-counsel for Netlist on their ‘high-wire act’
Netlist’s recent $44

6th ones the charm
😄

SPY almost $548 sweet molasses

Check the form 4 again. What does it show as the transaction date? What was the closing price that day (also near the lod)?

The transaction was dated 7/26, Friday. I'm guessing that JJ agreed to pay Friday's closing price.

Apologies I shouldn't have said no drop outs at week 36 - 48 in dosed there were still some but at lowest rate. Placebo had highest drop out week 36-48 and was at same level as 50mg group for weeks 24-36.

No... Making one itty-bitty payment ... Greg Mitchell STILL has not admitted to the Pretzel Haus lawsuit and 233,674.48-dollar Judgment. There are many other debt that are going unpaid. Grillit is in debt to around a million bucks to toxic lenders, and who knows what else Greg Has not disclosed.

I'm beginning to think FDA approval is just a pipe dream.

Assuming we are status quo in next quarter, Our revenue for the next quarter will be $67.5 minus $15 from China minus 1/3 loss of revenue from PBM. It looks live we will see a loss of $8M next quarter? [(67.5 -15 - 1/3(67.5-15)) = $35 - 43.3 = -8.3]

Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there are still

Ha!! Too funny!! it's a DEVELOPMENT contract, it's NOT a commercial contract

so good for them, they need something to do to keep themselves busy trying to stabilize their fragile molecules, the cross-linking is helping but it is NOT enough for commercial applications!!!!

Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there are still

Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class

Reminder, Plug Power webinar "Hydrogen: Facts vs. Fiction" today at 12:00 PM ET
Register at https://event.on24.com/wcc/r/4646223/6A711449FB0745E74159CEEAEBDC1066?partnerref=CorpEventsPg

Background
Despite reality and the advances that have been made with hydrogen, there

RMB- I think delisting is not a terrible fate when you consider that this company will soon be in a battle to remain north of the $100m / year in total revenues. The business plan seems to be to keep the spend to an absolute minimum while time is bought for the progress of getting row onboard and s